Application of morphometrics as a predictor for survival in female patients with breast cancer spinal metastasis, a retrospective cohort study

The current standard of care for prediction of survival of cancer staging is based on TNM staging. However, for patients with spinal metastasis, who all have identical stage IV disease, identifying accurate prognostic markers of survival would allow better treatment stratification between more aggressive treatment strategies or palliation. Analytic morphometrics enables physicians to quantify patient frailty by measuring lean muscle mass. Morphometrics also predicts survival in patients with lung cancer metastases to the spine.

from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2tMm1dZ
via IFTTT